BL(SZ:002592)2019-10-29 16:00Financial Performance - Operating revenue for the current period was CNY 168,931,660.35, representing a 12.72% increase year-on-year[7]. - Net profit attributable to shareholders was CNY 3,190,777.41, a 24.33% increase compared to the same period last year[7]. - The net profit attributable to shareholders of the listed company was -¥9,614,288.22, a decrease of 172.42% from ¥13,275,272.46 in the previous year, reflecting a decline of ¥22,889,560.68[20]. - The net profit for the period was CNY 10,155,632.09, significantly up from CNY 2,566,503.21, marking an increase of 295.5%[70]. - The company's net profit for Q3 2019 was a loss of CNY 12,059,792.88, compared to a profit of CNY 8,826,801.77 in Q3 2018, indicating a significant decline in profitability[75]. - The company's total comprehensive income for Q3 2019 was a loss of CNY 12,059,792.88, compared to a gain of CNY 8,826,801.77 in Q3 2018, reflecting a challenging financial environment[75]. Assets and Liabilities - Total assets increased by 30.07% to CNY 3,117,774,393.22 compared to the end of the previous year[7]. - The total liabilities increased to CNY 975,862,955.01 from CNY 536,002,012.32, representing an increase of approximately 82.2%[61]. - The company's current assets decreased to CNY 803,884,834.48 from CNY 860,642,752.41 at the end of 2018, indicating a decline of approximately 6.6%[60]. - The non-current assets increased to CNY 2,313,889,558.74 from CNY 1,536,427,852.17, reflecting an increase of approximately 50.5%[60]. - The company's equity attributable to shareholders decreased slightly to CNY 1,851,316,199.00 from CNY 1,860,840,666.00, a decrease of about 0.5%[62]. Cash Flow - Net cash flow from operating activities decreased by 389.08% to -CNY 37,808,676.41[7]. - The net cash flow from operating activities was -¥18,741,038.36, a decrease of 132.10% compared to ¥58,379,577.43 in the same period last year, a reduction of ¥77,120,615.79[21]. - The net cash flow from investing activities was -¥445,911,179.34, a decrease of 192.46% from ¥482,284,754.35 in the previous year, reflecting a decline of ¥928,195,933.69[21]. - The company's cash flow from financing activities was -¥57,747,857.41, a decrease of 69.04% compared to -¥186,510,404.86 in the previous year, reflecting a reduction of ¥128,762,547.45[22]. Shareholder Information - The total number of shareholders at the end of the reporting period was 21,403[11]. - The largest shareholder, Yang Jingzhong, holds 33.45% of the shares, with 37,200,000 shares pledged[11]. - The company did not engage in any repurchase transactions during the reporting period[12]. - The company transferred 28,333,000 shares (10% of total shares) from controlling shareholder Yang Jingzhong to Wang Anxiang, with the agreement effective after shareholder approval[33]. Investments and Acquisitions - The company acquired 51% equity in Beijing Hongrun Tianyuan Gene Biotechnology Co., Ltd. for a total payment of ¥58,270.57 million, with a remaining payment of ¥32,504.75 million[25]. - The company invested ¥2,000,000 in Shenzhen Wangbo Smart Toilet Innovation Technology Co., Ltd., acquiring a 20% stake, with a total payment of ¥700,000 made so far[26]. - The company invested ¥6,600,000 in Dahua Mawang Kehua Biotechnology Co., Ltd., acquiring a 22% stake, with a total payment of ¥3,000,000 made so far[27]. - The company received a total of ¥65,397,916.67 from the transfer of its investment in Gaia Bailing, including a principal amount of ¥54,564,583.34 and guaranteed returns of ¥10,833,333.33[30]. Employee Stock Ownership Plan - As of the announcement date, the first three phases of the employee stock ownership plan hold a total of 9,598,290 shares, accounting for 3.39% of the total share capital[35]. - The first phase of the employee stock ownership plan completed stock purchases of 9,933,789 shares, totaling approximately 293.69 million yuan[35]. - The second phase of the employee stock ownership plan purchased 3,615,134 shares, with a total transaction amount of approximately 122.88 million yuan[37]. - The third phase of the employee stock ownership plan acquired 13,484,121 shares, with a total transaction amount of approximately 419.99 million yuan[39]. - The company plans to transfer repurchased shares to the fourth phase of the employee stock ownership plan at an adjusted price of 12.58 yuan per share[44]. Research and Development - Research and development expenses rose to CNY 6,529,911.07, up from CNY 4,440,983.63, indicating a 47% increase year-over-year[69]. - Research and development expenses for the year-to-date period were CNY 16,305,914.69, an increase from CNY 15,510,004.67, highlighting the company's commitment to innovation[76]. Other Financial Metrics - Basic earnings per share remained at CNY 0.01, unchanged from the previous period[7]. - The weighted average return on net assets was 0.17%, an increase of 0.12 percentage points compared to the previous year[7]. - The company reported a gross profit margin of approximately 5.5% for the quarter, compared to 1.8% in the previous year[69]. - The company reported a credit impairment loss of CNY 19,916,620.02 in Q3 2019, which was not present in the same period last year, impacting overall profitability[73].